We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

176 hedge funds and large institutions have $1.23B invested in Acorda Therapeutics in 2015 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 50 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 50

33% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 21

4% more funds holding

Funds holding: 170 → 176 (+6)

19% less capital invested

Capital invested by funds: $1.51B → $1.23B (-$283M)

75% less call options, than puts

Call options by funds: $2.15M | Put options by funds: $8.69M

Holders
176
Holders Change
+6
Holders Change %
+3.53%
% of All Funds
4.91%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
28
Increased
69
Reduced
50
Closed
21
Calls
$2.15M
Puts
$8.69M
Net Calls
-$6.55M
Net Calls Change
-$6.55M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$35M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$25.9M
3
SCM
Scopia Capital Management
New York
+$18.3M
4
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$16.5M
5
Millennium Management
Millennium Management
New York
+$13.7M

Top Sellers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
-$56.1M
2
TCM
Tekla Capital Management
Massachusetts
-$22.7M
3
EAM
Eagle Asset Management
Florida
-$13.7M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$9.87M
5
Renaissance Technologies
Renaissance Technologies
New York
-$9.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
TPSF
101
Texas Permanent School Fund
Texas
$939K -$31K -8 -3%
WT
102
Whittier Trust
California
$868K – – –
CAM
103
ClariVest Asset Management
California
$851K -$23.3K -6 -2%
Axa
104
Axa
France
$835K -$1.24M -321 -55%
MLICM
105
Metropolitan Life Insurance Company (MetLife)
New York
$813K – – –
AIG
106
American International Group
New York
$813K +$7.76K +2 +0.8%
CC
107
CQS Cayman
Cayman Islands
$809K +$985K +254 New
Susquehanna International Group
108
Susquehanna International Group
Pennsylvania
$798K +$535K +138 +122%
ERSOT
109
Employees Retirement System of Texas
Texas
$795K – – –
Federated Hermes
110
Federated Hermes
Pennsylvania
$795K – – –
D.E. Shaw & Co
111
D.E. Shaw & Co
New York
$794K +$648K +167 +204%
DCM
112
Dupont Capital Management
Delaware
$788K +$140K +36 +17%
CSS
113
Cubist Systematic Strategies
Connecticut
$699K +$586K +151 +219%
Royal London Asset Management
114
Royal London Asset Management
United Kingdom
$604K +$737K +190 New
PIM
115
Partner Investment Management
California
$587K +$85.3K +22 +14%
AA
116
AlphaMark Advisors
Kentucky
$583K – – –
DekaBank Deutsche Girozentrale
117
DekaBank Deutsche Girozentrale
Germany
$570K +$23.3K +6 +3%
ASRS
118
Arizona State Retirement System
Arizona
$544K +$663K +171 New
ACPU
119
Arrowgrass Capital Partners (US)
Delaware
$530K +$648K +167 New
OC
120
Oppenheimer & Co
New York
$505K +$252K +65 +69%
LSERS
121
Louisiana State Employees Retirement System
Louisiana
$501K – – –
USAA
122
United Services Automobile Association
Texas
$485K -$27.1K -7 -4%
Citigroup
123
Citigroup
New York
$465K +$399K +103 +240%
Citadel Advisors
124
Citadel Advisors
Florida
$450K +$551K +142 New
CWG
125
C WorldWide Group
Denmark
$432K +$11.6K +3 +2%
3 4
5
6 7

ACOR Hedge Fund Activity: Q3 2015 in Review

176 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2015, worth a combined $1.23B — down 19% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ACOR positions and 21 closed out — a net gain of 7 holders — while 69 added to existing stakes and 50 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $35M. The largest seller was UBS AM, cutting an estimated $56.1M.

  • 176 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2015, up from 170 in Q2 2015.
  • Funds reported $1.23B of Acorda Therapeutics stock for Q3 2015, down 19% quarter-over-quarter.
  • 28 funds opened new Acorda Therapeutics positions in Q3 2015 and 21 closed out, a net change of +7 holders.
  • The largest Acorda Therapeutics buyer in Q3 2015 was Point72 Asset Management, an estimated $35M added.
  • The largest Acorda Therapeutics seller in Q3 2015 was UBS AM, an estimated $56.1M sold.

Based on aggregated 13F filings for Q3 2015.